FDA Investigator Kenneth E Felkley

Kenneth E Felkley has inspections in 3 countries as of 24 Jul 2023. Kenneth E Felkley has collaborated with a combined 1872 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
24 Jul 2023
Investigator Role:
FDA Investigator
Redica ID:
United States of America, Netherlands, Germany
Allison C Hunter, Allison E Sincek, Andrew J Barrowcliff, Andrew M Kupper, Andria L Kuhlman, Anna M Brannen, Arie R Dyk, Bailey A Uetrecht, Benjamin D Shuler, Bethany L Subel, Brenda C Hamilton, Brigitte K Hofmann, Byeongtaek Oh, Carl A Huffman, III, Charanjeet Jassal, Christina Capacci Daniel, PhD, Christina L Bigham, Christopher T Middendorf, Craig P Seaborn, Craig T Rybus, Cynthia T Cain, D Yvette Barnett, David S Jackson, Dell S Moller, Dina K West, Douglas A Campbell, Dyvette Arline, Edward R Kay, Elizabeth Ll Edwards, Emily J Orban, Genevieve E Ghand, Gilbert J Heidenblut, Gilbert J Herbert, Green, Heather A Mccauley, Hugh M Mcclure, II, James G Marsh, James Norman, Janet L Bowen, Jeffrey D Meng, Jennifer L Gustavus, Jennifer L Sheehan, Jennifer L Shehan, Jerry J Corwin, Jill J Tillman, Jill R Loeliger, Jill R Raezer, John E Russell, Jon P Antoniou, Joseph X Kaufman, Joshua P Wireman, Joshua S Hunt, Kathleen D Culver, Kathryn Suttling, Katie L Korchinski, Lauren N Howard, Lauren N Smith, Lauren R Collins, Lindsey M Schwierjobann, Lindsey M Schwierjohann, Lisa R Hilliar, Logan T Williams, Maney P Sturgill, Marianne Allen, Mark E Parmon, Mary B Sheets, Mary E Storch, Matthew B Casale, Michael D Thatcher, Michael E Clark, Michael P Sheehan, Michael R Goga, Nadeem I Chaudhry, Nicholas L Paulin, Nina Ni, Paraluman S Leonin, Paranthaman Senthamaraikannan, Patrick C Klotzbuecher, Phillip M Pontikos, Pifer, Randy L Self, Robert M Barbosa, Rosanna M Goodrich, Rosanna M Vaccaro, Roy C Stephens, Samantha J Bradley, Sarah E Rhoades, State Agency, Steven B Hertz, Steven P Eastham, Susan M Taylor, Susanna E Ford, Analyst, Sydney S Choi, Tamara M Kays, Tarun D Mehta, Teresa K Kastner, Thomas J Arista, Thomas J Prigge, Thomas W Nojek, Tracey L Harris, Ucheabuchi C Chudi Nwankwor, Unnee Ranjan, Vipulchandr N Dholakia, Wen Ning Chan (Sally), Ying Zhang

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more